Sun Pharma jumps 5% on series of clarifications

The drug major said that its domestic formulations distribution shall be transitioned from Aditya Medisales, the current distributor, to a wholly-owned subsidiary of Sun Pharma.

Sebi starts probe against Sun Pharma, to also reopen insider trading case

Premium

SI Reporter New Delhi

Last Updated : Jan 22 2019 | 10:29 AM IST

Shares of Sun Pharma jumped as much as 5.1 per cent to Rs 418.70 in the early trade on BSE after the company made a series of clarifications and changes in its filing to the bourses.

The drug major said that its domestic formulations distribution shall be transitioned from Aditya Medisales, the current distributor, to a wholly-owned subsidiary of Sun Pharma and the change will be made effective by Q1FY20, post receipt of all requisite regulatory approvals. CLICK HERE TO READ THE PRESS PRELEASE

This apart, the firm also announced unwinding of a transaction with Atlas Global

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in